Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors

Details for Australian Patent Application No. 2004207658 (hide)

Owner Sanofi-Synthelabo

Inventors Van Dorsselaer, Viviane; Despeyroux, Pierre; Schoentjes, Bruno; Frehel, Daniel

Agent Davies Collison Cave

Pub. Number AU-B-2004207658

PCT Pub. Number WO2004/067520

Priority 03/00703 23.01.03 FR

Filing date 22 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 29 October 2009

International Classifications

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/067520 Priority application(s): WO2004/067520

29 October 2009 Application Accepted

  Published as AU-B-2004207658

25 February 2010 Standard Patent Sealed

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207665-Organic-inorganic hybrid material containing a mineral mesoporous phase and an organic phase, a membrane and fuel cell

2004207657-Aryl alkyl carbamate derivatives production and use thereof in therapy